Rennova Health Inc (RNVA)
0.0000
0.00 (0.00%)
USD |
OTCM |
May 07, 15:46
Rennova Health Shareholders Equity (Quarterly): -29.91M for Sept. 30, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2022 | -29.91M |
June 30, 2022 | -28.57M |
March 31, 2022 | -28.57M |
September 30, 2021 | -37.51M |
June 30, 2021 | -41.34M |
March 31, 2021 | -52.91M |
December 31, 2020 | -49.02M |
September 30, 2020 | -40.54M |
June 30, 2020 | -61.32M |
March 31, 2020 | -82.29M |
December 31, 2019 | -76.52M |
September 30, 2019 | -67.66M |
June 30, 2019 | -55.65M |
March 31, 2019 | -47.90M |
December 31, 2018 | -39.17M |
September 30, 2018 | -30.13M |
June 30, 2018 | -129.95M |
March 31, 2018 | -183.91M |
December 31, 2017 | -40.61M |
September 30, 2017 | -18.79M |
June 30, 2017 | -17.52M |
March 31, 2017 | -65.33M |
December 31, 2016 | -14.89M |
September 30, 2016 | -10.04M |
June 30, 2016 | -10.94M |
Date | Value |
---|---|
March 31, 2016 | -5.428M |
September 30, 2015 | 6.172M |
June 30, 2015 | 7.055M |
March 31, 2015 | 7.936M |
December 31, 2014 | 1.272M |
September 30, 2014 | 2.284M |
June 30, 2014 | 3.155M |
March 31, 2014 | 2.925M |
December 31, 2013 | 3.755M |
September 30, 2013 | 4.661M |
June 30, 2013 | 5.133M |
March 31, 2013 | 5.704M |
December 31, 2012 | 6.404M |
September 30, 2012 | 7.361M |
June 30, 2012 | 7.455M |
March 31, 2012 | 8.08M |
December 31, 2011 | 10.36M |
September 30, 2011 | 8.049M |
June 30, 2011 | 8.446M |
March 31, 2011 | 9.409M |
December 31, 2010 | 9.798M |
September 30, 2010 | 9.882M |
June 30, 2010 | 9.724M |
March 31, 2010 | 11.94M |
December 31, 2009 | 16.98M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-82.29M
Minimum
Mar 2020
-28.57M
Maximum
Mar 2022
-50.14M
Average
-49.02M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 12.65M |
AIM ImmunoTech Inc | 10.23M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 3.314M |
Protalix BioTherapeutics Inc | 33.57M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 20.29M |
Total Liabilities (Quarterly) | 50.20M |